Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Urinary Bladder Neoplasms 1Neoplastic Cells, Circulating 1Neoplasm Metastasis 1Carcinoma, Lobular 1Breast Neoplasms 1

Interventions

Carboplatin 4Trastuzumab 3Cyclophosphamide 3Paclitaxel 2Letrozole 2Fulvestrant 2Docetaxel 2repotrectinib 1proto-oncogene protein c-fes-fps 1palbociclib 1neratinib 1entrectinib 1Vorinostat 1Vinorelbine 1Thiotepa 1Taxes 1Tamoxifen 1Sugars 1Radiotherapy 1Positron Emission Tomography Computed Tomography 1Neoadjuvant Therapy 1Naltrexone 1Melphalan 1Mastectomy, Segmental 1Magnetic Resonance Spectroscopy 1Liquid Biopsy 1High-Energy Shock Waves 1Goserelin 1Fluorine-18 1Epirubicin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Carcinoma, Lobular × Liquid Biopsy × Clear all
NCT06067503 2026-04-13

Biomarkers to Detect Endocrine Therapy Resistance

University of Wisconsin, Madison

Phase 2 Recruiting
8 enrolled
Breast

Breast Neoplasms, Neoplastic Cells, Circulating, Neoplasm Metastasis, Carcinoma, Lobular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡